Search Details

Word: publicizers (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Both Kim and Fauci emphasize that it will probably be a "significant period of time" before the trial results lead to a vaccine that can be submitted for approval for use in the general public, if such a breakthrough occurs at all. Most licensed vaccines have an efficacy rate of at least 70%, although it's possible that an HIV vaccine with lower efficacy may gain approval, Kim says. "The efficacy threshold may be a consideration that is specific to individual countries, the nature of their HIV-AIDS epidemics and the performance characteristics of the vaccine," Kim says...

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

...university's study (the biggest of its kind so far), published Sept. 23 in PLoS One, the online scientific journal of the U.S. Public Library of Science, scientists analyzed close to 300,000 patients admitted to state-run hospitals across England on those two Wednesdays from 2000 to 2008. The health of the patients, who were split evenly between the July and August admission days, was tracked for a week. While there was little difference between the crude death rates for each seven-day period, when researchers controlled for the patients' age, sex, socioeconomic status and secondary medical problems...

Author: /time Magazine | Title: Can New Doctors Be Harmful to Your Health? | 9/25/2009 | See Source »

About 40 million doses of the vaccine should be ready by mid-October, with an additional 10 to 20 million doses added each week through the end of the year. The 2009 H1N1 vaccine will be free, with public distribution in most areas. Among those the government has prioritized for the voluntary vaccine: all school-age children, pregnant women, caretakers of young babies and people with chronic health conditions that could weaken their immune systems. In Spokane, Springer is carefully tracking the numbers to see how the illness behaves before local school children have a chance to be vaccinated...

Author: /time Magazine | Title: Ahead of Schedule, H1N1 Flu Season Arrives in the U.S. | 9/25/2009 | See Source »

Midway through “Generosity,” Richard Powers’ stunning new novel, the charming businessman and geneticist Robert Kurton participates in a public debate with an unnamed novelist. The subject: genetic enhancement of human beings. The shy author begins, awkwardly reading from a prewritten speech. But his argument is complex, as Powers writes, “The writer’s thought is so dense that every clause tries to circle back for another try before plunging on.” Even the narration has trouble following the train of thought. Kurton takes stage, joking...

Author: By Adam L. Palay, CONTRIBUTING WRITER | Title: Acclaimed Novelist Powers Perfects His Aesthetic | 9/25/2009 | See Source »

...recent nation-wide survey by the Harvard School of Public Health found that most businesses believe they will suffer significant operational difficulties in the event of a widespread H1N1 outbreak...

Author: By Helen X. Yang, CRIMSON STAFF WRITER | Title: Firms Expect H1N1 To Affect Operations | 9/25/2009 | See Source »

Previous | 523 | 524 | 525 | 526 | 527 | 528 | 529 | 530 | 531 | 532 | 533 | 534 | 535 | 536 | 537 | 538 | 539 | 540 | 541 | 542 | 543 | Next